These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7075646)

  • 1. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
    Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
    Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
    Siber GR; Gorham CC; Ericson JF; Smith AL
    Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR; Wilson C; Holazo A
    Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.
    Martea M; Hekster YA; Vree TB; Voets AJ; Berden JH
    Pharm Weekbl Sci; 1987 Apr; 9(2):110-6. PubMed ID: 3495778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].
    Rieder VJ; Schwartz DE
    Arzneimittelforschung; 1975 Apr; 25(4):656-66. PubMed ID: 1174084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP; Gronwall R; Castro L
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis ].
    de Fremont JF; Schmit JL; Thomas D; Coevoet B; Eb F; Laurence G; Orfila J; Fournier A
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):581-4. PubMed ID: 6750528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tolerance of a single twelve-tablet dose of trimethoprim (960 mg)-sulfamethoxazole (4,800 mg).
    Fass RJ; Prior RB; Perkins RL
    Antimicrob Agents Chemother; 1977 Jul; 12(1):102-6. PubMed ID: 883811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the trimethoprim-sulphamethoxazole combination in the elderly.
    Varoquaux O; Lajoie D; Gobert C; Cordonnier P; Ducreuzet C; Pays M; Advenier C
    Br J Clin Pharmacol; 1985 Dec; 20(6):575-81. PubMed ID: 3879182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Co-trimoxazole concentration in the prostatic fluid of patients with subacute and chronic prostatitis].
    Hofstetter A; Friesen A; Bishop-Freudling GB; Vergin H
    Fortschr Med; 1984 Mar; 102(9):244-6. PubMed ID: 6608482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal distribution of trimethoprim and sulfamethoxazole.
    Trottier S; Bergeron MG; Lessard C
    Antimicrob Agents Chemother; 1980 Mar; 17(3):383-8. PubMed ID: 7425603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
    Grossman PL; Remington JS
    Am J Trop Med Hyg; 1979 May; 28(3):445-55. PubMed ID: 453442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
    Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
    J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.
    Overturf GD
    Rev Infect Dis; 1987; 9 Suppl 2():S168-76. PubMed ID: 3554455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gonorrhea with trimethoprim-sulfamethoxazole.
    Elliott WC; Reynolds G; Thornsberry C; Kellogg DS; Jaffe HW; Brown ST; Armstrong J; Rein MF
    J Infect Dis; 1977 Jun; 135(6):939-43. PubMed ID: 405433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral or intravenous trimethoprim-sulfamethoxazole therapy for shigellosis.
    Nelson JD; Kusmiesz H; Shelton S
    Rev Infect Dis; 1982; 4(2):546-50. PubMed ID: 6981170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung tissue diffusion of intravenous trimethoprim-sulfamethoxazole combination (author's transl)].
    Morel C; Langeard M; Vergnaud M; Monrocq N
    Pathol Biol (Paris); 1982 Jun; 30(6):380-4. PubMed ID: 7050846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
    Hughes DT; Russell NJ
    Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.